grant

Protection Against Nosocomial Infections After Severe Burn Injury Through Trained Immunity

Organization VANDERBILT UNIVERSITY MEDICAL CENTERLocation NASHVILLE, UNITED STATESPosted 1 May 2021Deadline 30 Apr 2031
NIHUS FederalResearch GrantFY2026AddressAgonistAwardBiogenesisBlood NeutrophilBlood Polymorphonuclear NeutrophilBlood leukocyteBlood monocyteBurn injuryBurnsCell BodyCell EnergeticsCellsCellular Immune FunctionDangerousnessDevelopmentDysfunctionEnsureFK506 Binding Protein 12-Rapamycin Associated Protein 1FKBP12 Rapamycin Complex Associated Protein 1FRAP1FRAP1 geneFRAP2Functional disorderGlycolysisHospital InfectionsHospital acquired infectionHumanImmuneImmune Cell ActivationImmune DiseasesImmune DisordersImmune DysfunctionImmune MarkersImmune System DiseasesImmune System DisorderImmune System DysfunctionImmune System and Related DisordersImmune mediated therapyImmune systemImmunesImmunityImmunocompromisedImmunocompromised HostImmunocompromised PatientImmunologic DiseasesImmunologic MarkersImmunological DiseasesImmunological DysfunctionImmunological System DysfunctionImmunologically Directed TherapyImmunosuppressed HostImmunosuppressionImmunosuppression EffectImmunosuppressive EffectImmunotherapyImpairmentIndividualInfectionIntermediary MetabolismK pneumoniaeK. pneumoniaeKlebsiella pneumoniaeLeukocytesLeukocytes Reticuloendothelial SystemLifeLipid AMacrophageMarrow NeutrophilMarrow leukocyteMarrow monocyteMechanistic Target of RapamycinMediatingMetabolicMetabolic ProcessesMetabolic dysfunctionMetabolismMethodologyMiceMice MammalsMitochondriaModelingModern ManMolecularMorbidityMurineMusMyeloid CellsNeutrophilic GranulocyteNeutrophilic LeukocyteNosocomial InfectionsOrigin of LifeP aeruginosaP. aeruginosaPBMCPathway interactionsPatientsPeripheral Blood Mononuclear CellPhysiopathologyPolymorphonuclear CellPolymorphonuclear LeukocytesPolymorphonuclear NeutrophilsPopulationPseudomonas aeruginosaPseudomonas pyocyaneaRAFT1RecoveryResearchResistance to infectionS aureusS. aureusSamplingStaph aureusStaphylococcus aureusTLR proteinTherapeuticToll-Like Receptor Family GeneToll-like receptorsTrainingTranslational InhibitionTranslational RepressionWhite Blood CellsWhite CellWorkanti-microbialantimicrobialburn modelburnedclinical relevanceclinically relevantdevelopmentalexhaustionfightingflexibilityflexiblefunctional outcomesimmune activationimmune functionimmune suppressionimmune suppressive activityimmune suppressive functionimmune therapeutic approachimmune therapeutic interventionsimmune therapeutic regimensimmune therapeutic strategyimmune therapyimmune-based biomarkersimmune-based therapiesimmune-based treatmentsimmuno therapyimmunological biomarkersimmunological markersimmunosuppressed patientimmunosuppressive activityimmunosuppressive functionimmunosuppressive responseimprovedinfection resistanceinnovateinnovationinnovativeinstitutional infectionmTORmammalian target of rapamycinmitochondrialmonocytemortalityneutrophilnew drug treatmentsnew drugsnew pharmacological therapeuticnew therapeuticsnew therapynext generation therapeuticsnovel drug treatmentsnovel drugsnovel pharmaco-therapeuticnovel pharmacological therapeuticnovel therapeuticsnovel therapypathogenpathophysiologypathwayprogramsrecruitresponsescRNA sequencingscRNA-seqserious burnssevere burnssingle cell RNA-seqsingle cell RNAseqsingle cell expression profilingsingle cell transcriptomic profilingsingle-cell RNA sequencingwhite blood cellwhite blood corpusclewound assessmentwound carewound monitoring
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

PROJECT SUMMARY
Severe burn injuries result in immune and metabolic dysfunction, leaving patients vulnerable to life-threatening

infections, which remain a leading cause of morbidity and mortality. These vulnerabilities arise from immune

exhaustion, metabolic impairments, and disrupted leukocyte function, leading to prolonged

immunosuppression.…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →